The Department of Health says South Africa is making significant progress in rolling out lenacapavir, a twice-yearly injectable medication used to prevent HIV infection. Since its national launch in June, more than 55,000 people have started using lenacapavir, with women, particularly pregnant and breastfeeding mothers, making up the majority of recipients. Gauteng has recorded the highest uptake, with more than 26,000 initiations. We're joined by Dr Nonnhlanhla Ndlovu: DDG for HIV/AIDS, TB, Maternal and Child Health at the Department of Health to unpack the rollout, demand and safety of this new HIV prevention option.